<?xml version='1.0' encoding='utf-8'?>
<document id="28087250"><sentence text="Pharmacology of cannabinoids in the treatment of epilepsy."><entity charOffset="16-28" id="DDI-PubMed.28087250.s1.e0" text="cannabinoids" /></sentence><sentence text="The use of cannabis products in the treatment of epilepsy has long been of interest to researchers and clinicians alike; however, until recently very little published data were available to support its use" /><sentence text=" This article summarizes the available scientific data of pharmacology from human and animal studies on the major cannabinoids which have been of interest in the treatment of epilepsy, including ∆9-tetrahydrocannabinol (∆9-THC), cannabidiol (CBD), ∆9-tetrahydrocannabivarin (∆9-THCV), cannabidivarin (CBDV), and ∆9-tetrahydrocannabinolic acid (Δ9-THCA)"><entity charOffset="114-126" id="DDI-PubMed.28087250.s3.e0" text="cannabinoids" /><entity charOffset="195-218" id="DDI-PubMed.28087250.s3.e1" text="∆9-tetrahydrocannabinol" /><entity charOffset="220-226" id="DDI-PubMed.28087250.s3.e2" text="∆9-THC" /><entity charOffset="229-240" id="DDI-PubMed.28087250.s3.e3" text="cannabidiol" /><entity charOffset="242-245" id="DDI-PubMed.28087250.s3.e4" text="CBD" /><entity charOffset="248-273" id="DDI-PubMed.28087250.s3.e5" text="∆9-tetrahydrocannabivarin" /><entity charOffset="275-282" id="DDI-PubMed.28087250.s3.e6" text="∆9-THCV" /><entity charOffset="285-299" id="DDI-PubMed.28087250.s3.e7" text="cannabidivarin" /><entity charOffset="301-305" id="DDI-PubMed.28087250.s3.e8" text="CBDV" /><entity charOffset="312-342" id="DDI-PubMed.28087250.s3.e9" text="∆9-tetrahydrocannabinolic acid" /><entity charOffset="344-351" id="DDI-PubMed.28087250.s3.e10" text="Δ9-THCA" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e0" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e1" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e2" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e3" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e4" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e5" e2="DDI-PubMed.28087250.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e5" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e5" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e5" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e5" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e5" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e6" e2="DDI-PubMed.28087250.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e6" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e6" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e6" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e6" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e7" e2="DDI-PubMed.28087250.s3.e7" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e7" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e7" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e7" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e8" e2="DDI-PubMed.28087250.s3.e8" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e8" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e8" e2="DDI-PubMed.28087250.s3.e10" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e9" e2="DDI-PubMed.28087250.s3.e9" /><pair ddi="false" e1="DDI-PubMed.28087250.s3.e9" e2="DDI-PubMed.28087250.s3.e10" /></sentence><sentence text=" It has long been known that ∆9-THC has partial agonist activity at the endocannabinoid receptors CB1 and CB2, though it also binds to other targets which may modulate neuronal excitability and neuroinflammation"><entity charOffset="29-35" id="DDI-PubMed.28087250.s4.e0" text="∆9-THC" /><entity charOffset="72-87" id="DDI-PubMed.28087250.s4.e1" text="endocannabinoid" /><pair ddi="false" e1="DDI-PubMed.28087250.s4.e0" e2="DDI-PubMed.28087250.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28087250.s4.e0" e2="DDI-PubMed.28087250.s4.e1" /></sentence><sentence text=" The actions of Δ9-THCV and Δ9-THCA are less well understood"><entity charOffset="16-23" id="DDI-PubMed.28087250.s5.e0" text="Δ9-THCV" /><entity charOffset="28-35" id="DDI-PubMed.28087250.s5.e1" text="Δ9-THCA" /><pair ddi="false" e1="DDI-PubMed.28087250.s5.e0" e2="DDI-PubMed.28087250.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28087250.s5.e0" e2="DDI-PubMed.28087250.s5.e1" /></sentence><sentence text=" In contrast to ∆9-THC, CBD has low affinity for CB1 and CB2 receptors and other targets have been investigated to explain its anticonvulsant properties including TRPV1, voltage gated potassium and sodium channels, and GPR55, among others"><entity charOffset="16-22" id="DDI-PubMed.28087250.s6.e0" text="∆9-THC" /><entity charOffset="24-27" id="DDI-PubMed.28087250.s6.e1" text="CBD" /><entity charOffset="184-193" id="DDI-PubMed.28087250.s6.e2" text="potassium" /><entity charOffset="198-204" id="DDI-PubMed.28087250.s6.e3" text="sodium" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e0" e2="DDI-PubMed.28087250.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e0" e2="DDI-PubMed.28087250.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e0" e2="DDI-PubMed.28087250.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e0" e2="DDI-PubMed.28087250.s6.e3" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e1" e2="DDI-PubMed.28087250.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e1" e2="DDI-PubMed.28087250.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e1" e2="DDI-PubMed.28087250.s6.e3" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e2" e2="DDI-PubMed.28087250.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28087250.s6.e2" e2="DDI-PubMed.28087250.s6.e3" /></sentence><sentence text=" We describe the absorption, distribution, metabolism, and excretion of each of the above mentioned compounds" /><sentence text=" Cannabinoids as a whole are very lipophilic, resulting in decreased bioavailability, which presents challenges in optimal drug delivery"><entity charOffset="1-13" id="DDI-PubMed.28087250.s8.e0" text="Cannabinoids" /></sentence><sentence text=" Finally, we discuss the limited drug-drug interaction data available on THC and CBD"><entity charOffset="73-76" id="DDI-PubMed.28087250.s9.e0" text="THC" /><entity charOffset="81-84" id="DDI-PubMed.28087250.s9.e1" text="CBD" /><pair ddi="false" e1="DDI-PubMed.28087250.s9.e0" e2="DDI-PubMed.28087250.s9.e0" /><pair ddi="false" e1="DDI-PubMed.28087250.s9.e0" e2="DDI-PubMed.28087250.s9.e1" /></sentence><sentence text=" As cannabinoids and cannabis-based products are studied for efficacy as anticonvulsants, more investigation is needed regarding the specific targets of action, optimal drug delivery, and potential drug-drug interactions"><entity charOffset="4-16" id="DDI-PubMed.28087250.s10.e0" text="cannabinoids" /></sentence><sentence text=" This article is part of a Special Issue titled Cannabinoids and Epilepsy"><entity charOffset="48-60" id="DDI-PubMed.28087250.s11.e0" text="Cannabinoids" /></sentence><sentence text="" /></document>